|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-10-26
|
|
pubmed:abstractText |
Our work evaluated the potential role of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) serum levels with respect to that of conventional serum tumour markers, CEA and CA 15-3, in monitoring the course of metastatic breast cancer in 56 female patients treated with cytotoxic chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1010-4283
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright (c) 2006 S. Karger AG, Basel.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
302-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:17028465-Adult,
pubmed-meshheading:17028465-Aged,
pubmed-meshheading:17028465-Angiogenic Proteins,
pubmed-meshheading:17028465-Breast Neoplasms,
pubmed-meshheading:17028465-Female,
pubmed-meshheading:17028465-Fibroblast Growth Factor 2,
pubmed-meshheading:17028465-Humans,
pubmed-meshheading:17028465-Middle Aged,
pubmed-meshheading:17028465-Neoplasm Metastasis,
pubmed-meshheading:17028465-Postmenopause,
pubmed-meshheading:17028465-Premenopause,
pubmed-meshheading:17028465-Reproducibility of Results,
pubmed-meshheading:17028465-Tumor Markers, Biological,
pubmed-meshheading:17028465-Vascular Endothelial Growth Factor A
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Do serum angiogenic growth factors provide additional information to that of conventional markers in monitoring the course of metastatic breast cancer?
|
|
pubmed:affiliation |
Istituto Oncologico Romagnolo, Forlì, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
